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associated with treatment retention, while use of heroin, 
crack, and multiple drugs, psychiatric problems in the previ-
ous month, and lifetime depression were negatively asso-
ciated with treatment retention. Higher perceived medical 
pressure resulted in higher treatment retention rates only
for participants in QCT.  Conclusion:  Predictors of substance 
abuse treatment retention are quite similar across both QCT 
and voluntary treatments. Perceived medical pressure is of 
higher relevance than the often-believed legal pressure for 
treatment retention in QCT.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 There is an increasing interest in the use of criminal 
justice systems to direct drug-related offenders into treat-
ment that potentially reduces harm  [1, 2] , is cost-effective 
 [1, 3] , and relieves overloaded prisons  [2, 3] . In a recent 
study, we demonstrated that treatment of such offenders 
reduces substance use and crime and improves health 
and social integration similarly to voluntary treatment 
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 Abstract 
 Background: Policies and practices related to the quasi-
compulsory treatment (QCT) of substance-dependent of-
fenders are currently implemented in many countries, de-
spite the absence of reliable knowledge about significant 
predictors of treatment retention. This study aimed to iden-
tify such predictors in QCT and voluntary treatment.  Meth-
ods: Participants were treated in one of 65 institutions in
5 European countries. They were interviewed at intake on 
substance use, crimes committed, perceived pressure for 
treatment, self-efficacy, stage of change, employment, and 
health-related variables. Binary logistic regression models 
were computed to identify predictors of treatment retention 
at an 18-month follow-up. Moderator analyses were com-
puted to investigate whether these predictors vary by treat-
ment condition (QCT vs. voluntary).  Results: A higher num-
ber of working days in the previous month was positively 
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 [4] . However, at present only a few substance-dependence 
treatment programmes for prisoners are available (e.g. 
substitution therapy or naltrexone prescription  [1, 5] ). 
Those available are often limited to emergency cases, and 
implementation varies between European and American 
prisons  [6] . The literature shows that a majority of sub-
stance-dependent inmates resume drug use and criminal 
activities after release into the community  [3, 6] . Provid-
ing treatment services to substance-dependent offenders 
in a non-prison-related institution is therefore a useful 
alternative to incarceration  [1, 6, 7] .
 We define quasi-compulsory treatment (QCT) as sub-
stance abuse/dependence therapy that is motivated, or-
dered, or supervised by the criminal justice system but 
that takes place outside of prisons. Other forms of com-
pulsory treatment as regulated by social care and mental 
health laws are excluded from this definition. Arrange-
ments for QCT differ among the various European coun-
tries and the many drug policies in US courts. European 
programmes are not limited to drug offenders and are 
often used for persistent offenders who would be exclud-
ed from several of the systems used by American drug 
courts  [8] .
 Generally, the literature suggests that QCT is at least 
as effective as voluntary treatment in reducing substance 
use and crime  [1, 8, 9] . Furthermore, legal compulsion is 
believed to improve retention in treatment  [6, 10] . How-
ever, we must emphasise that a large proportion of re-
search that compares QCT to voluntary treatment for 
substance users is non-empirical in nature  [8] . Addition-
ally, a majority of empirical studies fail to use adequate 
comparison groups, and those that do generally fail to 
differentiate among primary substances of abuse and em-
ploy rather short follow-up periods  [6] . Moreover, recent 
US studies argue that results must be viewed in terms of 
very complex, specific criminal justice treatment delivery 
systems  [8, 11] and their unique organisational contexts 
 [12] .
 Thus far, little attention has been paid to the effects of 
baseline variables in predicting the retention of QCT; in 
particular, there have not been adequate comparisons to 
voluntary treatment. The current knowledge of the pre-
dictors of retention in QCT is based only on the few stud-
ies detailed below.
 Substance Use and Criminality 
 The association between illicit drug use and offending 
has often been discussed [13]. There is a clear association 
between these behaviours, but the explanations and caus-
al directions of this link are not clear [14–16]. Pertaining 
to predictors of treatment retention, social conformity 
and the experience of either gunshots or stabbing pre-
dicts at intake retention in an alternative non-prison res-
idential drug treatment programme  [17] . In a more recent 
study, lengthier criminal histories at intake predicted 
treatment drop-outs among court-mandated substance-
abusing offenders  [18] .
 Perceived Pressure and Coercion 
 Research on legally coerced drug treatment is ongo-
ing, with mixed results reported internationally  [1, 6–8] . 
It has been suggested that people who are coerced into 
drug treatment will not be motivated to change  [19] and 
may therefore be less likely to engage and succeed in 
treatment  [20] . Some studies argue that motivation is a 
good predictor of retention in the treatment of drug de-
pendence  [11, 21, 22] , although others suggest that moti-
vation is less important than factors such as therapeutic 
alliance and their perceived utility  [23] .
 It is important to distinguish between the various 
sources of perceived coercion (e.g. coercion from legal au-
thorities, family, or an employer), as it is likely that differ-
ent forms of coercion produce different treatment out-
comes and retention rates  [6] . Previous research combin-
ing different measures of coercion has produced some 
interesting results. For example, an American study in 3 
inpatient therapeutic communities found that perceived 
legal pressure predicts better retention, while pressure 
from families predicts worse retention  [24] . Stevens et al. 
 [25] suggested that participants entering QCT perceive 
more pressure, but this does not necessarily lead to high-
er or lower motivation than under voluntary treatment. 
They suggest that motivation is mutable and that it can 
be enhanced or diminished by the quality of support and 
services in QCT.
 Psychiatric Disorders 
 There are 2 US studies that report on predictors for 
treatment retention and drop-out. In the first, the exis-
tence of a psychiatric history predicted the completion of 
treatment at intake in an alternative non-prison residen-
tial drug treatment programme  [17] . In the second study, 
more severe psychiatric problems at intake predicted 
treatment drop-outs among court-mandated, substance-
abusing offenders  [18] .
 Employment Status 
 According to a large study on retention data that in-
vestigated deterrents against the premature termination 
of treatment in offenders referred to long-term residential 
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treatment, the lack of legitimate job opportunities acted 
as a deterrent, similar to criminal sanctions against drug 
offenses  [26] . In a study by Evans et al.  [18] , more se-
vere employment problems at intake predicted treatment 
drop-outs in court-mandated, substance-abusing offend-
ers. In another study, the strongest predictors of success 
in court-mandated SUD treatment were factors associ-
ated with social stakeholder values, especially those in-
volving employment  [27] .
 Self-Efficacy 
 In methadone-maintained patients undergoing volun-
tary treatment, higher levels of self-efficacy at intake are 
related to lower drug use after 12 months  [28] and to more 
frequent cocaine-negative urine samples  [29] . So far, no 
studies have reported on self-efficacy as a potential pre-
dictor on treatment retention in both voluntary and co-
erced SUD treatment.
 Motivation 
 Substance users differ in the extent to which they are 
motivated to change, become therapeutically engaged in 
treatment, or sustain recovery following treatment  [30] . 
Treatment motivation has not been found to be signifi-
cantly different between individuals in a substance use, 
prison-based treatment programme for legal and illegal 
substances versus individuals in the general prison popu-
lation  [31] . In the study by Evans et al.  [18] , lower treat-
ment motivation at intake predicted treatment drop-outs 
in their population of court-mandated, substance-abus-
ing offenders.
 The current study investigated predictors and mod-
erators of retention in QCT and voluntary treatment. 
Predictors specify which individuals are likely to have 
better treatment retention irrespective of compulsive or 
voluntary admission. Moderators specify whether there 
are differences in the predictors of treatment retention 
due to quasi-compulsive or voluntary admission.
 Methods 
 Services and Participant Selection 
 Services from the United Kingdom, Italy, Austria, Germany, 
and Switzerland were selected if they treated participants eligible 
for either QCT or voluntary groups  [4, 25] . The QCT group was 
defined as participants receiving treatment on court order (i.e. 
having or awaiting a court sentence for QCT) as an optional al-
ternative to imprisonment or other punishment in a regular inpa-
tient or outpatient treatment institution. The voluntary group was 
defined as persons entering treatment institutions in which QCT 
was also available. A total of 65 treatment institutions that re-
cruited participants for both QCT and voluntary groups were in-
cluded in this study. Within these institutions, a total of 430 QCT 
and 415 voluntary treatment participants were recruited.
 Inpatient treatment almost exclusively included abstinence-
oriented drug addiction treatment after detoxification. Partici-
pants in outpatient treatment with opiate addiction were predom-
inantly treated in substitution programmes. In the voluntary 
group, treatment length was dependent on treatment concepts 
(i.e. inpatient) or individual decisions (i.e. outpatient). There were 
no differences in the treatment concepts for participants in the 
QCT and voluntary groups within the institutions – both groups 
received essentially the same treatment. QCT participants were 
more often assigned to inpatient treatment than voluntary par-
ticipants (50.1 vs. 34.7%, p  ! 0.01). The mean expected treatment 
duration was 410.9 days (SD = 192.6). Non-compliance in the 
QCT group was dependent on regulations in the respective coun-
tries; QCT participants failing treatment were at risk of being sen-
tenced to prison in most countries. Out of 65 institutions, 42 (pri-
marily larger ones) filled out the Treatment Unit Form (TUF)  [32] . 
According to the TUF, all responding institutions provided indi-
vidual treatment planning. Job assistance was provided in 90% of 
the institutions, vocational training in 85%, housing assistance in 
80%, financial assistance in 81%, and aftercare in 90%. Relapse 
prevention was provided in 83% of the institutions. On average, 
25.9 h (SD = 25.4) of group therapy and group counselling were 
provided per month. Individual therapy and counselling were 
provided on average for 4.9 h (SD = 3.4) per month.
 Participants in the QCT group were enrolled in the study at 
intake and provided informed consent for participation and for 
the use of their medical and police records. All participants were 
asked at intake by service staff to provide informed consent, were 
assured that all information would be handled confidentially, and 
were informed that they had the right to withdraw at any time 
without consequence to their treatment and/or court sentence (if 
applicable). The study protocol was approved by national or local 
ethics committees, as appropriate. All participants were paid be-
tween EUR 10 and 20 per follow-up interview to promote reten-
tion in the study. Detailed outcomes of the follow-up study will be 
published elsewhere.
 Measures and Data Collection 
 We used the ASI-crime module (ASI-C)  [33] and the European 
Addiction Severity Index (EuropASI)  [34] , with items omitted 
that are not on the ‘critical objective EuropASI items’ list  [35] to 
reduce the time needed to administer the instrument. Institutions 
were invited to verify patient self-reports in the EuropASI by com-
paring urine analyses with reported urine test results from patient 
case histories. Moreover, we used Hiller’s  [11] initial assessment 
form for correctional inpatient treatment to assess the extent to 
which respondents felt pressured by various sources. We also used 
an adapted version of the Proactive Coping Scale  [36] and the 
Readiness-to-Change Questionnaire (RCQ)  [37] . The RCQ was 
used to assign respondents to different stages of Prochaska and 
Diclemente’s stages of change model  [38] (i.e. the precontempla-
tion, contemplation, or action stage). For this study, the precon-
templation and contemplation stages were collapsed to obtain a 
dichotomous variable for predictor and moderator analyses. Al-
though the concept of stages of change has been criticised  [39] , 
there is a wide consensus that people who state that they are will-
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ing to stop using drugs are more likely to succeed than those who 
do not  [40] . All of these measures were used at intake as well as at 
6-, 12-, and 18-month follow-up interviews. Intake interviews 
were administered after detoxification (i.e. abstinence-oriented 
treatments) or appropriate stabilisation (i.e. substitution treat-
ments). None of the participants were prescribed antagonist treat-
ment. Interview guidelines and questionnaires unavailable in the 
required languages were translated with back translations. Par-
ticipant interviews were completed face-to-face with external in-
terviewers who were not from the treatment institutions but rath-
er were trained in the use of the EuropASI.
 To assess reasons for treatment drop-out relevant to the cur-
rent investigation, information was collected immediately after 
drop-out from a patient’s therapeutic and/or legal contact along 
with medical and police records.
 Definition of Retention 
 Participants were subdivided into (1) a group with treatment 
retention, (2) a group without treatment retention, and (3) a group 
with ambiguous treatment retention. Participants were assigned 
to the group with treatment retention if they (1) completed 
planned treatment, (2) remained in or (3) re-entered treatment. 
Participants were assigned to the group without treatment reten-
tion if they were (1) (re-)arrested, (2) excluded from treatment 
service, (3) died within 18 months after intake, (4) chose to leave 
(i.e. participants who left treatment without a subsequent treat-
ment and/or further treatment within 18 months and who were 
not included in one of the other categories), or (5) had the QCT 
revoked by the court (i.e. participants whose QCT arrangement 
was revoked and who did not re-enter treatment within 18 
months). Participants were assigned to the group with ambiguous 
treatment retention if (1) they moved abroad, (2) they revoked in-
formed consent, (3) they were repatriated, or (4) their data records 
were ambiguous, insufficient, or missing.
 Statistical Analyses 
 Intake differences between the QCT and voluntary groups 
were analysed using   2 statistics for categorical variables and ad-
justed Wald test statistics for continuous variables. Given the clus-
tered nature of the data (i.e. participants within treatment institu-
tions), the   2 statistics were corrected for the clustered design and 
then converted into F statistics. We calculated effect sizes for in-
take variables, which differed significantly between the QCT and 
voluntary groups. Cohen’s  d (0.2 = small effect, 0.5 = medium ef-
fect,  0.8  =  large  effect)  was  calculated for continuous variables; 
 w (0.1 = small effect, 0.3 = medium effect, 0.5 = large effect) was 
calculated for categorical variables.
 Binary logistic regression analyses were computed to explore 
the predictors and moderators of treatment retention compared 
to the reference group without treatment retention. Participants 
with ambiguous retention were not considered in the predictor 
and moderator analyses. Separate logistic regressions were per-
formed to evaluate the ability of each intake variable to predict 
treatment retention, regardless of compulsory or voluntary ad-
mission. After examining these univariate predictors, a multivar-
iate prediction model was developed. Variable selection involved 
the following steps: (1) Significant predictors (p  ! 0.05) from the 
univariate analyses were entered into the preliminary multivari-
ate model. (2) Variables not significant at p  ! 0.05 were removed 
one by one; variables with the highest p values were removed first 
(i.e. backward selection). (3) To account for suppressor effects, the 
resulting model was verified by tentatively adding the aforemen-
tioned excluded variables separately to the regression model. 
Only variables significant at p  ! 0.05 were retained in the model 
(i.e. forward selection).
 Statistical analyses of moderators were performed following 
the guidelines of Kraemer et al.  [41] for evaluating moderators of 
treatment effects. Dichotomous intake variables (including QCT 
versus voluntary treatment) were coded as 0.5 or –0.5, and con-
tinuous intake variables were centred at their mean. The logistic 
regression models to test the moderators included the treatment 
group (i.e. QCT versus voluntary treatment) by intake variable 
interaction while controlling for the main effects of both the 
treatment group and intake variable. Significant moderator ef-
fects (p  ! 0.05) were graphically illustrated by plotting the reten-
tion rates for different values of the moderator according to the 
treatment group.
 Due to the clustering of participants within treatment groups, 
we computed robust variance estimators for all logistic regression 
models. All analyses were performed using Stata version 10, and 
an alpha level of 0.05 (2-tailed) was chosen for the statistical tests.
 Results 
 Intake Descriptions 
 Participant intake characteristics for the QCT and vol-
untary groups are shown in  table 1 . There was a higher 
proportion of male participants in the QCT group (86.1%) 
than in the voluntary group (77.4%, p = 0.01, effect size 
 w  = 0.11). Furthermore, the QCT and voluntary groups 
differed in terms of the number of years of school educa-
tion, with a higher educational level in the voluntary 
group (10.1 years, QCT group 9.6 years, p = 0.01,  d = 0.21). 
Concerning substance use, there was a lower percentage 
of crack users in the voluntary group (11.4%, QCT group 
28.3%, p = 0.00,  w = 0.21), but participants in the volun-
tary group had more years of excessive alcohol use (4.5 
years, QCT group 3.1 years, p = 0.04,  d = 0.20). Ninety 
percent of the participants in the QCT group had com-
mitted at least 1 high-severity crime at some point (e.g. 
burglary, firearm-related offences, or other weapons of-
fences). The percentage of high-severity crimes was lower 
in the voluntary group (70.2%, p = 0.00,  w = 0.25). Par-
ticipants in the QCT group perceived more pressure from 
legal authorities (QCT group 2.9, voluntary group 1.4, 
p = 0.00,  d = 1.19) but less from families and/or friends 
(QCT group 2.1, voluntary group 2.3, p = 0.01,  d = 0.17) 
and from themselves (QCT group 3.5, voluntary group 
3.8,  p  =  0.00,  d = 0.19). Self-efficacy was slightly higher 
in the QCT group (3.4) than in the voluntary group (3.3, 
p = 0.04,  d = 0.17), but there was no difference in the per-
centage of participants in the action stage of change be-
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tween the groups. The longest period of unemployment 
was higher in the QCT group (4.7 years) than in the vol-
untary group (3.2 years, p = 0.00,  d = 0.32). The number 
of days listed as sick in the previous month was higher in 
the voluntary group (5.5 days, QCT group 2.9 days, p = 
0.01,  d = 0.27). There were no differences between the 
groups in terms of the percentage of medical care used in 
the previous 6 months or in the prevalence of various psy-
chiatric problems ( table 1 ).
 Treatment Retention 
 Of the 845 participants, 449 (53.1%) were categorised 
into the group with treatment retention, while 257 (30.4%) 
were categorised into the group without treatment reten-
tion; for 139 participants (16.4%), data concerning treat-
ment retention were missing or ambiguous. Using data 
from the 706 participants with unambiguous data for 
treatment retention, we did not find differences in treat-
ment retention between the QCT and voluntary groups 
(retention: QCT group 67.8%, voluntary group 59.4%,  F = 
2.21, p = 0.15).
Table 1.  Participant intake characteristics of QCT and voluntary groups
QCT group
(n = 430)
Voluntary
group (n = 415)
p Effect
size
Age, years 31.687.5 31.087.6 0.43
Male 86.1% 77.4% 0.01 w = 0.11
Married 11.2% 11.8% 0.85
School education, years 9.682.1 10.182.2 0.01 d = 0.21
Substance use
Heroin (last month) 54.8% 50.4% 0.52
Heroin (lifetime), years of use 6.985.8 6.285.5 0.13
Cocaine (last month) 40.8% 39.9% 0.88
Cocaine (lifetime), years of use 5.185.1 4.785.0 0.45
Crack (last month) 28.3% 11.4% 0.00 w = 0.21
Multiple drug use (last month) 60.9% 55.3% 0.44
Ever injected 70.2% 71.3% 0.77
Problematic alcohol use (last month) 19.9% 24.2% 0.30
Excessive alcohol, years of use 3.185.7 4.588.0 0.04 d = 0.20
Committed high-severity crimes (ever) 90.0% 70.2% 0.00 w = 0.25
Perceived pressure 
Medical pressure 1.581.0 1.480.9 0.54
Families and/or friends 2.181.4 2.381.4 0.01 d = 0.17
Employer 1.180.5 1.180.6 0.43
Legal authorities 2.981.6 1.480.9 0.00 d = 1.19
Self 3.581.5 3.881.4 0.00 d = 0.19
Others 1.380.9 1.380.9 0.86
Self-efficacy 3.480.5 3.380.5 0.04 d = 0.17
Action stage of change 46.0% 43.2% 0.49
Employment and health
Number of working days (last month) 5.7810.6 3.388.0 0.11
Longest period of unemployment, years 4.784.9 3.284.2 0.00 d = 0.32
Number of days listed as sick (last month) 2.988.6 5.5810.9 0.01 d = 0.27
Medical care (last 6 months) 46.7% 54.0% 0.08
Homeless (last month) 20.5% 14.3% 0.07
Serious psychiatric problems (last month) 57.0% 58.8% 0.71
Serious depression (lifetime) 56.9% 64.0% 0.10
Serious anxiety or tension (lifetime) 59.0% 64.0% 0.18
Serious suicidal thoughts (lifetime) 42.0% 48.7% 0.14
Serious hallucinations (lifetime) 20.8% 18.4% 0.48
Data are means 8 SD or percentages, as appropriate. 
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 Predictors of Treatment Retention  
 Univariate Analyses. Univariate predictors of treat-
ment retention are shown in  table 2 . A higher age (OR = 
1.03, CI 1.00–1.05) and a higher number of working days 
in the previous month (OR = 1.03, CI 1.01–1.06) were pos-
itively associated with treatment retention. Heroin use in 
the previous month (OR = 0.60, CI 0.37–0.97), crack use 
in  the previous month (OR = 0.48, CI 0.26–0.87), multi-
ple drug use in the previous month (OR = 0.41, CI 0.24–
0.68), serious psychiatric problems in the previous month 
(OR = 0.65, CI 0.47–0.92), and serious lifetime depression 
(OR = 0.71, CI 0.52–0.96) were negatively associated with 
treatment retention.
 Multivariate Analysis. The final multivariate regres-
sion model predicting treatment retention included the 
variables ‘multiple drug use in the previous month’, 
which was negatively associated with retention (OR = 
0.45, CI 0.28–0.70, p  ! 0.01), and the ‘number of working 
days in the previous month’, which was positively associ-
ated with retention (OR = 1.03, CI 1.00–1.06, p = 0.04).
 Variables Moderating the Effect of Treatment 
Condition on Treatment Retention 
 The moderator analyses revealed that medical pres-
sure moderated the effect of compulsory versus voluntary 
admission on treatment retention (OR = 0.70, 95% CI 
0.51–0.95, p = 0.05). Higher perceived medical pressure 
resulted in higher treatment retention rates only for par-
ticipants in the QCT group, while comparable retention 
rates were achieved for participants with high and low 
levels of perceived medical pressure in the voluntary 
group ( fig. 1 ). Furthermore, multiple drug use moderated 
the effect of compulsory versus voluntary admission on 
treatment retention (OR = 1.98, 95% CI 1.44–2.71, p  ! 
0.01). Multiple drug use had a significantly stronger effect 
leading to lower treatment retention rates for participants 
in the QCT group compared to participants in the volun-
tary group. However, multiple drug use resulted in lower 
rates of treatment retention for both the QCT and volun-
tary groups ( fig. 2 ). No moderating effect was found in 
the other intake variables, especially not for perceived 
pressure from the legal system (p  1 0.05).
 Discussion 
 The strength of the current study is in the prospective 
data and the results based on an extensive number of in-
dividuals undergoing QCT and voluntary treatment 
from various institutions within 5 European countries 
over a period of 18 months. The study revealed 3 main 
results. First, predictors of treatment retention were 
quite similar under both QCT and voluntary treatment. 
Second, a number of intake characteristics predicted 
treatment retention in both groups, with multiple drug 
use and the number of working days in the previous 
month as the best predictors. Third, perceived pressure 
from legal authorities at intake did not moderate reten-
tion in the QCT group in contrast to voluntary treat-
ment, whereas perceived medical pressure was a relevant 
moderator.
Table 2.  Intake predictors of treatment retention
Variable OR 95% CI
Age 1.03* 1.00–1.05
Male 1.04 0.68–1.58
Married 0.98 0.59–1.61
School education in years 0.94 0.86–1.04
Substance use
Heroin (last month) 0.60* 0.37–0.97
Heroin (lifetime years of use) 1.02 0.99–1.06
Cocaine (last month) 0.65 0.41–1.02
Cocaine (lifetime years of use) 0.98 0.95–1.02
Crack (last month) 0.48* 0.26–0.87
Multiple drug use (last month) 0.41** 0.24–0.68
Ever injected 0.81 0.52–1.27
Problematic alcohol use (last month) 0.85 0.50–1.45
Excessive alcohol (years of use) 1.02 0.99–1.05
Committed high-severity crimes 0.84 0.55–1.29
Perceived pressure
Medical pressure 1.23 0.97–1.57
Families and/or friends 0.95 0.84–1.07
Employer 1.38 0.94–2.03
Legal authorities 1.13 0.99–1.29
Self 0.98 0.88–1.09
Others 1.16 0.93–1.45
Self-efficacy 1.41 0.97–2.07
Action stage of change 1.13 0.80–1.58
Employment and health
Number of working days (last month)
Longest period of unemployment (years)
Number of days listed as sick (last month)
Medical care (last 6 months)
Homeless (last month)
Serious psychiatric problems (last month)
Serious depression (lifetime)
Serious anxiety or tension (lifetime)
Serious suicidal thoughts (lifetime)
Serious hallucinations (lifetime)
1.03*
0.98
0.99
0.85
0.73
0.65*
0.71*
0.97
0.90
0.84
1.01–1.06
0.93–1.02
0.97–1.01
0.59–1.24
0.48–1.10
0.47–0.92
0.52–0.96
0.69–1.35
0.63–1.27
0.53–1.33
S eparate binary logistic regression model for each intake vari-
able. * p < 0.05; ** p < 0.01.
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 The first main result has a number of implications, of 
which we now discuss only a few. First of all, together 
with the comparison of treatment outcomes in an earlier 
publication  [4] , this finding supports QCT as an effective 
alternative to imprisonment for drug-related offenders. 
Typically, the majority of substance-dependent prison in-
mates resume drug use and criminal activities after re-
lease into the community  [6] .
 The presence of heroin, crack, and multiple drug use 
in the previous month was negatively associated with 
treatment retention. Interestingly, multiple drug use had 
a stronger negative effect on treatment retention for par-
ticipants in the QCT group, but crack use did not have a 
negative moderating effect on treatment retention in this 
group. According to post hoc analyses, this might result 
from a confounding admission effect. Subjects in the 
QCT group were more often assigned to inpatient treat-
ment, and this could have specifically retained crack us-
ers in treatment who frequently demonstrate severe crav-
ing symptoms in the first weeks of abstinence, symptoms 
that can persist for months.
 In line with previous studies suggesting that employ-
ment is associated with better treatment retention  [18, 
27] , a higher number of working days in the previous 
month was positively associated with treatment retention 
in both the univariate and multivariate analyses. This 
underscores the importance of employment for QCT and 
voluntary treatment, although this result is expected to 
be confounded, as those who had employment before in-
take are likely the ones with less severe characteristics.
 The third main finding highlights the importance of 
distinguishing among the various sources of perceived 
coercion  [25] for participants in QCT versus voluntary 
treatment. Furthermore, this finding contradicts the of-
ten-reported belief that legal compulsion improves treat-
ment retention  [6, 20] , which is based mainly on empiri-
cal studies that fail to use adequate comparison groups or 
employ rather short follow-up periods  [6, 8] . However, we 
could not confirm perceived family pressure as a relevant, 
negative predictor in a study on 3 US therapeutic com-
munities  [24] .
 The presence of at least 1 high-severity crime commit-
ted over the course of a patient’s lifetime did not (nega-
tively) predict treatment retention and did not moderate 
treatment retention with respect to quasi-compulsory or 
voluntary admission, although the presence of such a his-
tory was more prevalent in the QCT group. Consequent-
ly, QCT should not be restricted to offenders who com-
mitted typical substance abuse-related crimes such as 
drug trafficking, prostitution, and so on, as is common 
in several American drug court systems  [8] .
 In line with Evans et al.  [18] , serious psychiatric prob-
lems in the previous month and serious lifetime depres-
sion were negatively associated with treatment retention. 
No predictive relevance was found for the action stage of 
change. This finding supports existing critiques of the 
concept of stages of change  [39] . Self-efficacy did not pre-
dict treatment retention, as we had expected based on its 
predictive results on substance use outcomes in meth-
adone-maintained patients under voluntary treatment 
 [28, 29] . However, due to the diverse sample consisting of 
heroin, cocaine/crack, multiple drug and alcohol abusers, 
it was not possible to calculate reliable predictors of treat-
ment outcomes, which would have been a more accurate 
80.0
64.5
Quasi-compulsory treatment
63.1
58.3
Voluntary treatment
Perceived medical pressure high
Perceived medical pressure low
55.3
85.0
Quasi-compulsory treatment
53.1
65.6
Voluntary treatment
Poly drug use in previous month
No poly drug use in previous month
 Fig. 1. Perceived medical pressure moderating the effect of quasi-
compulsory vs. voluntary treatment on treatment retention. 
Numbers indicate percentage of treatment retained.  
 Fig. 2. Multiple drug use in the previous month moderating the 
effect of quasi-compulsory vs. voluntary treatment on treatment 
retention. Numbers indicate percentage of treatment retained.  
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test for the potential corroboration of these previous re-
sults.
 A limitation of the current study relates to the self-
reported nature of the frequencies of substance use and 
crime. Urine analyses could not be systematically collect-
ed due to funding limitations. However, institutions were 
instructed to verify and correct participant self-reports 
on substance use and crime measures in the baseline 
 EuropASI interviews based on reported urine test results 
from patient case histories. An additional limitation was 
that applied treatment methods differed among the insti-
tutions involved, although participants in the QCT and 
voluntary groups were for the most part treated in the 
same institutions using the same treatment concepts. Ap-
proximately one third of each group was still in treatment 
after 18 months; thus, the predictor calculations are not 
based on final outcomes, which is a clear limitation in our 
study. However, we expected only a small portion of the 
participants still in treatment after 18 months to later 
demonstrate a negative outcome or revocation or to leave 
treatment without a follow-up treatment because most of 
these outcome events occurred in the first 6 months of 
this study.
 In view of the current study’s results, we conclude that 
predictors of treatment retention were generally quite 
similar under both quasi-compulsory and voluntary 
treatment. More specifically, perceived medical pressure 
was of higher relevance than the often-believed legal 
pressure for predicting treatment retention in quasi-com-
pulsory treatment.
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